60
Participants
Start Date
June 30, 2007
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
ibritumomab tiuxetan
0.4 mCi/kg
BEAM chemotherapy and autologous stem-cell transplantation
Mayo Clinic, Rochester
Mayo Clinic Arizona, Scottsdale
Cedars Sinai Medical Center, Los Angeles
Moffitt Cancer Center, Tampa
Northwestern University, Chicago
Georg-August Universität, Göttingen
Chaim Sheba Medical Center, Tel Litwinsky
VU Medical Center, Amsterdam
City of Hope National Medical Center, Duarte
City of Hope Medical Center
OTHER
Amsterdam UMC, location VUmc
OTHER
University of Göttingen
OTHER
Sheba Medical Center
OTHER_GOV